Bozek, T., Blazekovic, A., Perkovic, M. N., Jercic, K. G., Sustar, A., Smircic-Duvnjak, L., . . . Borovecki, F. (2017). The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetol Metab Syndr.
Citação norma ChicagoBozek, Tomislav, Antonela Blazekovic, Matea Nikolac Perkovic, Kristina Gotovac Jercic, Aleksandra Sustar, Lea Smircic-Duvnjak, Tiago F. Outeiro, Nela Pivac, and Fran Borovecki. "The Influence of Dopamine-beta-hydroxylase and Catechol O-methyltransferase Gene Polymorphism On the Efficacy of Insulin Detemir Therapy in Patients With Type 2 Diabetes Mellitus." Diabetol Metab Syndr 2017.
MLA citiranjeBozek, Tomislav, et al. "The Influence of Dopamine-beta-hydroxylase and Catechol O-methyltransferase Gene Polymorphism On the Efficacy of Insulin Detemir Therapy in Patients With Type 2 Diabetes Mellitus." Diabetol Metab Syndr 2017.